
Pharmacogenomic testing for DPYD polymorphisms prior to fluoropyrimidine chemotherapy
In November 2020, NHS England issued an urgent policy statement confirming the routine commissioning of pharmacogenomic testing prior to the initiation of fluoropyrimidine chemotherapy.1 This […]